Rigel Pharma: Formulating A Game Plan For 2026 [Seeking Alpha]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Seeking Alpha
RIGL raised 2025 revenue guidance to $285M–$290M, projecting 55%–59% commercial growth, driven by TAVALISSE, REZLIDHIA, and GAVRETO. 2026 is expected to be a transition year, with flat revenue and declining EPS due to higher R&D spend, before a return to double-digit growth in 2027. I maintain a conviction level of 3/5, plan disciplined position sizing, and will monitor OpEx, product trends, and clinical progress closely. Looking for a helping hand in the market? Members of Compounding Healthcare get exclusive ideas and guidance to navigate any climate. Learn More » We Are/DigitalVision via Getty Images It has been seven years since my first Rigel Pharmaceuticals ( RIGL ) article, where I was bullish on TAVALISSE and the company's impressive pipeline. I was eyeing a potential buy early in 2019 as the company More on my IG service Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportu
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? [Yahoo! Finance]Yahoo! Finance
- Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Rigel Provides Business Update and 2026 Outlook [Yahoo! Finance]Yahoo! Finance
- Rigel Provides Business Update and 2026 OutlookPR Newswire
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)PR Newswire
RIGL
Earnings
- 11/4/25 - Beat
RIGL
Sec Filings
- 1/12/26 - Form 8-K
- 12/29/25 - Form 4
- 12/10/25 - Form 8-K
- RIGL's page on the SEC website